Neonates’ gut microbiome influences risk of allergy, asthma
The microbes living in a baby’s gut within its first month of birth may directly impact the developing immune system as well as lead to a higher risk of allergies and asthma later in the childhood, finds a study.
Gut microbes play a key role in processing dietary components such as fats, giving them a powerful influence over whether anti-inflammatory or pro-inflammatory molecules end up in the gut, the researchers said. The findings showed that one-month-old infants without anti-inflammatory lipids possessed abnormally high levels of resident fungal species. These infants were at a three-fold higher risk of developing allergic reactions by age two and asthma by age four. Further, the researchers also detected different fats, including one associated with asthma in adults, called “12, 13 DIHOME” that could reduce the number of T-regulatory cells — whose job is to keep the rest of the immune system in check. On the other hand, the guts of neonates with healthy microbiomes contained a wide range of molecules that can reduce inflammation. These include a set of fat molecules, or lipids, that the researchers suspect nourishes immune cells called T-regulatory cells. The discovery represents an opportunity to develop new treatments that could stave off allergies and asthma before they become established in children, the researchers said. Currently, children are typically six or seven years old when they are diagnosed with asthma, which has no cure and has to be managed through medication. “But if the genesis of the disease is visible as a disruption of gut microbiota in the very earliest stages of postnatal life, it raises an exciting question: could we reengineer the community of microbes at-risk infants to prevent allergic asthma from developing?” said Susan Lynch, Associate Professor at University of California, San Francisco in US.